Publish Time: 2026-09-11 Origin: Bioteke Corporation
BioTeke Corporation announces FDA 510(k) clearance for its BioTeke® Multi-Drug Urine Test Cup, under reference number K261409. The clearance marks a new regulatory milestone for the company in the United States, as BioTeke welcomes inquiries from prospective distribution, OEM, and private-label partners.
The BioTeke Multi-Drug Urine Test Cup is part of the company’s in vitro diagnostic (IVD) product offering. Its FDA 510(k) clearance provides a specific regulatory reference for organizations evaluating the product for their U.S. portfolios.
For prospective partners, product evaluation begins with understanding the cleared device and its labeling. Organizations can request documentation from BioTeke to review the applicable intended use, available test configurations, and specifications against their purchasing and market requirements.
BioTeke welcomes discussions with distributors and diagnostic product businesses interested in the Multi-Drug Urine Test Cup.
Distribution inquiries can focus on product documentation, supply requirements, and potential cooperation in the target market.
OEM and private-label inquiries can address manufacturing requirements, branding, and packaging. Each proposed project requires confirmation of the relevant product configuration and regulatory requirements; the announced clearance should not be assumed to cover every customized version.
To support a focused discussion, prospective partners are encouraged to share their target market, preferred cooperation model, and anticipated purchasing requirements.
Interested in evaluating the BioTeke Multi-Drug Urine Test Cup for your product portfolio?
Contact BioTeke to request product specifications, clearance documentation, and information about distribution, OEM, or private-label cooperation. Please reference “Multi-Drug Urine Test Cup — K261409” in your inquiry.
Visit BioTeke Corporation to connect with the team.
Advancing Diagnostics. Escort for Life.